Inventor · disambiguated record
Jason Crawford
Also filed as: CRAWFORD JASON · CRAWFORD JASON B
20 granted patents·10 pending applications·381 citations·filing 2000–2024
95Inventor score
Top patents by PatentIndex Score
30 records- 0194US7354934B2Chemokine receptor binding heterocyclic compounds with enhanced efficacyANORMED INC·Filed 2005·Granted Apr 8, 2008·34 cites·10 claims
- 0294US6864265B2Chemokine receptor binding heterocyclic compoundsANORMED INC·Filed 2001·Granted Mar 8, 2005·42 cites·6 claims
- 0394US6750348B1Chemokine receptor binding heterocyclic compoundsANORMED INC·Filed 2000·Granted Jun 15, 2004·61 cites·30 claims
- 0493US7091217B2Chemokine receptor binding heterocyclic compoundsANORMED INC·Filed 2004·Granted Aug 15, 2006·31 cites·12 claims
- 0593US6835731B2Chemokine receptor binding heterocyclic compoundsANORMED INC·Filed 2001·Granted Dec 28, 2004·53 cites·10 claims
- 0693US6734191B2Chemokine receptor binding heterocyclic compoundsANORMED INC·Filed 2001·Granted May 11, 2004·35 cites·15 claims
- 0791US7332605B2Process for the synthesis of CXCR4 antagonistANORMED INC·Filed 2005·Granted Feb 19, 2008·26 cites·38 claims
- 0890US7723525B2Chemokine-binding heterocyclic compound salts, and methods of use thereofGENZYME CORP·Filed 2005·Granted May 25, 2010·20 cites·10 claims
- 0990US7354932B2Chemokine receptor binding heterocyclic compounds with enhanced efficacyANORMED INC·Filed 2003·Granted Apr 8, 2008·27 cites·21 claims
- 1089US8778967B2Chemokine receptor binding heterocyclic compounds with enhanced efficacyBRIDGER GARY·Filed 2012·Granted Jul 15, 2014·18 cites·20 claims
- 1188US7501518B2Methods of making 2,6-diaryl piperidine derivativesGENZYME CORP·Filed 2004·Granted Mar 10, 2009·19 cites·6 claims
- 1276US7396840B2Chemokine receptor binding heterocyclic compoundsGENZYME CORP·Filed 2006·Granted Jul 8, 2008·1 cites·9 claims
- 1375US10322111B2Chemokine receptor binding heterocyclic compounds with enhanced efficacyGENZYME CORP·Filed 2016·Granted Jun 18, 2019·1 cites·13 claims
- 1475US7312234B2Chemokine receptor binding heterocyclic compoundsANORMED·Filed 2004·Granted Dec 25, 2007·7 cites·6 claims
- 1573US7629337B2Chemokine receptor binding heterocyclic compoundsGENZYME CORP·Filed 2006·Granted Dec 8, 2009·1 cites·9 claims
- 1669US7084155B2Chemokine receptor binding heterocyclic compoundsANORMED·Filed 2004·Granted Aug 1, 2006·3 cites·15 claims
- 1768US2024294581A1Heterologous production of leupeptin in protease inhibitors and analogs thereofUNIV YALE·Filed 2024·Application pending·0 cites
- 1867US7183273B2Chemokine receptor binding heterocyclic compoundsANORMED INC·Filed 2004·Granted Feb 27, 2007·2 cites·10 claims
- 1967US2020000774A1Chemokine receptor binding heterocyclic compounds with enhanced efficacyGENZYME CORP·Filed 2019·Application pending·0 cites
- 2063US2015038509A1Chemokine Receptor Binding Heterocyclic Compounds With Enhanced EfficacyGENZYME CORP·Filed 2014·Application pending·0 cites
- 2163US2025207124A1Compositions and methods for expressing synthetic genetic elements across diverse microorganismsUNIV YALE·Filed 2023·Application pending·0 cites
- 2262US7807694B2Chemokine receptor binding heterocyclic compoundsGENZYME CORP·Filed 2006·Granted Oct 5, 2010·0 cites·4 claims
- 2362US2008167341A1Chemokine receptor binding heterocyclic compounds with enhanced efficacyBRIDGER GARY·Filed 2008·Application pending·0 cites
- 2461US11912742B2Heterologous production of leupeptin protease inhibitors and analogs thereofUNIV YALE·Filed 2021·Granted Feb 27, 2024·0 cites·8 claims
- 2561US2010105915A1Chemokine receptor binding heterocyclic compoundsBRIDGER GARY J·Filed 2009·Application pending·0 cites
- 2659US2022409589A1Chemokine receptor binding heterocyclic compounds with enhanced efficacyGENZYME CORP·Filed 2022·Application pending·0 cites
- 2757US2008090846A1Chemokine receptor binding heterocyclic compoundsBRIDGER GARY·Filed 2007·Application pending·0 cites
- 2849US2003220341A1Chemokine receptor binding heterocyclic compounds with enhanced efficacyFiled 2002·Application pending·0 cites
- 2941US12286398B2Anti-bacterial stilbene derivatives and methods of useUNIV YALE·Filed 2020·Granted Apr 29, 2025·0 cites·23 claims
- 3034US2019031650A1Dna alkylation and cross-linking agents as compounds and payloads for targeted therapiesUNIV YALE·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jason Crawford files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →